The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Smart Medication Inhalers Market Research Report 2025
Synopsis
Smart medication inhalers are inhalers with extra digital features, they link to an app on your phone or tablet to help you and your doctor manage your asthma better.
Global Smart Medication Inhalers market is projected to reach US$ 163.1 million in 2029, increasing from US$ 58 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Smart Medication Inhalers market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Smart Medication Inhalers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sensirion AG
3M
Teva Pharmaceutical Industries
Propeller Health
BreatheSuite
Adherium
CapMedic
Hailie
GlaxoSmithKline (GSK)
Cohero Health
Glenmark Pharma
Enerzair Breezhaler (Novartis)
Inspiro Medical (OPKO Health)
Philips Healthcare
Vectura
Boehringer Ingelheim
AstraZeneca
Novartis
Segment by Type
Metered-Dose Inhalers
Dry Powder Inhalers
Propellant-Free Multi-Dose Spray Inhalers
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Smart Medication Inhalers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Smart medication inhalers are inhalers with extra digital features, they link to an app on your phone or tablet to help you and your doctor manage your asthma better.
Global Smart Medication Inhalers market is projected to reach US$ 163.1 million in 2029, increasing from US$ 58 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Smart Medication Inhalers market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Smart Medication Inhalers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sensirion AG
3M
Teva Pharmaceutical Industries
Propeller Health
BreatheSuite
Adherium
CapMedic
Hailie
GlaxoSmithKline (GSK)
Cohero Health
Glenmark Pharma
Enerzair Breezhaler (Novartis)
Inspiro Medical (OPKO Health)
Philips Healthcare
Vectura
Boehringer Ingelheim
AstraZeneca
Novartis
Segment by Type
Metered-Dose Inhalers
Dry Powder Inhalers
Propellant-Free Multi-Dose Spray Inhalers
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Smart Medication Inhalers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Smart Medication Inhalers Market Overview
1.1 Product Overview and Scope of Smart Medication Inhalers
1.2 Smart Medication Inhalers Segment by Type
1.2.1 Global Smart Medication Inhalers Market Value Comparison by Type (2023-2029)
1.2.2 Metered-Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Propellant-Free Multi-Dose Spray Inhalers
1.3 Smart Medication Inhalers Segment by Application
1.3.1 Global Smart Medication Inhalers Market Value by Application: (2023-2029)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Smart Medication Inhalers Market Size Estimates and Forecasts
1.4.1 Global Smart Medication Inhalers Revenue 2018-2029
1.4.2 Global Smart Medication Inhalers Sales 2018-2029
1.4.3 Global Smart Medication Inhalers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Smart Medication Inhalers Market Competition by Manufacturers
2.1 Global Smart Medication Inhalers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Smart Medication Inhalers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Smart Medication Inhalers Average Price by Manufacturers (2018-2023)
2.4 Global Smart Medication Inhalers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Smart Medication Inhalers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Smart Medication Inhalers, Product Type & Application
2.7 Smart Medication Inhalers Market Competitive Situation and Trends
2.7.1 Smart Medication Inhalers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Smart Medication Inhalers Players Market Share by Revenue
2.7.3 Global Smart Medication Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Smart Medication Inhalers Retrospective Market Scenario by Region
3.1 Global Smart Medication Inhalers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Smart Medication Inhalers Global Smart Medication Inhalers Sales by Region: 2018-2029
3.2.1 Global Smart Medication Inhalers Sales by Region: 2018-2023
3.2.2 Global Smart Medication Inhalers Sales by Region: 2024-2029
3.3 Global Smart Medication Inhalers Global Smart Medication Inhalers Revenue by Region: 2018-2029
3.3.1 Global Smart Medication Inhalers Revenue by Region: 2018-2023
3.3.2 Global Smart Medication Inhalers Revenue by Region: 2024-2029
3.4 North America Smart Medication Inhalers Market Facts & Figures by Country
3.4.1 North America Smart Medication Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Smart Medication Inhalers Sales by Country (2018-2029)
3.4.3 North America Smart Medication Inhalers Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Smart Medication Inhalers Market Facts & Figures by Country
3.5.1 Europe Smart Medication Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Smart Medication Inhalers Sales by Country (2018-2029)
3.5.3 Europe Smart Medication Inhalers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Smart Medication Inhalers Market Facts & Figures by Country
3.6.1 Asia Pacific Smart Medication Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Smart Medication Inhalers Sales by Country (2018-2029)
3.6.3 Asia Pacific Smart Medication Inhalers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Smart Medication Inhalers Market Facts & Figures by Country
3.7.1 Latin America Smart Medication Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Smart Medication Inhalers Sales by Country (2018-2029)
3.7.3 Latin America Smart Medication Inhalers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Smart Medication Inhalers Market Facts & Figures by Country
3.8.1 Middle East and Africa Smart Medication Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Smart Medication Inhalers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Smart Medication Inhalers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Smart Medication Inhalers Sales by Type (2018-2029)
4.1.1 Global Smart Medication Inhalers Sales by Type (2018-2023)
4.1.2 Global Smart Medication Inhalers Sales by Type (2024-2029)
4.1.3 Global Smart Medication Inhalers Sales Market Share by Type (2018-2029)
4.2 Global Smart Medication Inhalers Revenue by Type (2018-2029)
4.2.1 Global Smart Medication Inhalers Revenue by Type (2018-2023)
4.2.2 Global Smart Medication Inhalers Revenue by Type (2024-2029)
4.2.3 Global Smart Medication Inhalers Revenue Market Share by Type (2018-2029)
4.3 Global Smart Medication Inhalers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Smart Medication Inhalers Sales by Application (2018-2029)
5.1.1 Global Smart Medication Inhalers Sales by Application (2018-2023)
5.1.2 Global Smart Medication Inhalers Sales by Application (2024-2029)
5.1.3 Global Smart Medication Inhalers Sales Market Share by Application (2018-2029)
5.2 Global Smart Medication Inhalers Revenue by Application (2018-2029)
5.2.1 Global Smart Medication Inhalers Revenue by Application (2018-2023)
5.2.2 Global Smart Medication Inhalers Revenue by Application (2024-2029)
5.2.3 Global Smart Medication Inhalers Revenue Market Share by Application (2018-2029)
5.3 Global Smart Medication Inhalers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sensirion AG
6.1.1 Sensirion AG Corporation Information
6.1.2 Sensirion AG Description and Business Overview
6.1.3 Sensirion AG Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sensirion AG Smart Medication Inhalers Product Portfolio
6.1.5 Sensirion AG Recent Developments/Updates
6.2 3M
6.2.1 3M Corporation Information
6.2.2 3M Description and Business Overview
6.2.3 3M Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 3M Smart Medication Inhalers Product Portfolio
6.2.5 3M Recent Developments/Updates
6.3 Teva Pharmaceutical Industries
6.3.1 Teva Pharmaceutical Industries Corporation Information
6.3.2 Teva Pharmaceutical Industries Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pharmaceutical Industries Smart Medication Inhalers Product Portfolio
6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.4 Propeller Health
6.4.1 Propeller Health Corporation Information
6.4.2 Propeller Health Description and Business Overview
6.4.3 Propeller Health Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Propeller Health Smart Medication Inhalers Product Portfolio
6.4.5 Propeller Health Recent Developments/Updates
6.5 BreatheSuite
6.5.1 BreatheSuite Corporation Information
6.5.2 BreatheSuite Description and Business Overview
6.5.3 BreatheSuite Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BreatheSuite Smart Medication Inhalers Product Portfolio
6.5.5 BreatheSuite Recent Developments/Updates
6.6 Adherium
6.6.1 Adherium Corporation Information
6.6.2 Adherium Description and Business Overview
6.6.3 Adherium Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Adherium Smart Medication Inhalers Product Portfolio
6.6.5 Adherium Recent Developments/Updates
6.7 CapMedic
6.6.1 CapMedic Corporation Information
6.6.2 CapMedic Description and Business Overview
6.6.3 CapMedic Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CapMedic Smart Medication Inhalers Product Portfolio
6.7.5 CapMedic Recent Developments/Updates
6.8 Hailie
6.8.1 Hailie Corporation Information
6.8.2 Hailie Description and Business Overview
6.8.3 Hailie Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hailie Smart Medication Inhalers Product Portfolio
6.8.5 Hailie Recent Developments/Updates
6.9 GlaxoSmithKline (GSK)
6.9.1 GlaxoSmithKline (GSK) Corporation Information
6.9.2 GlaxoSmithKline (GSK) Description and Business Overview
6.9.3 GlaxoSmithKline (GSK) Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GlaxoSmithKline (GSK) Smart Medication Inhalers Product Portfolio
6.9.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.10 Cohero Health
6.10.1 Cohero Health Corporation Information
6.10.2 Cohero Health Description and Business Overview
6.10.3 Cohero Health Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cohero Health Smart Medication Inhalers Product Portfolio
6.10.5 Cohero Health Recent Developments/Updates
6.11 Glenmark Pharma
6.11.1 Glenmark Pharma Corporation Information
6.11.2 Glenmark Pharma Smart Medication Inhalers Description and Business Overview
6.11.3 Glenmark Pharma Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Glenmark Pharma Smart Medication Inhalers Product Portfolio
6.11.5 Glenmark Pharma Recent Developments/Updates
6.12 Enerzair Breezhaler (Novartis)
6.12.1 Enerzair Breezhaler (Novartis) Corporation Information
6.12.2 Enerzair Breezhaler (Novartis) Smart Medication Inhalers Description and Business Overview
6.12.3 Enerzair Breezhaler (Novartis) Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Enerzair Breezhaler (Novartis) Smart Medication Inhalers Product Portfolio
6.12.5 Enerzair Breezhaler (Novartis) Recent Developments/Updates
6.13 Inspiro Medical (OPKO Health)
6.13.1 Inspiro Medical (OPKO Health) Corporation Information
6.13.2 Inspiro Medical (OPKO Health) Smart Medication Inhalers Description and Business Overview
6.13.3 Inspiro Medical (OPKO Health) Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Inspiro Medical (OPKO Health) Smart Medication Inhalers Product Portfolio
6.13.5 Inspiro Medical (OPKO Health) Recent Developments/Updates
6.14 Philips Healthcare
6.14.1 Philips Healthcare Corporation Information
6.14.2 Philips Healthcare Smart Medication Inhalers Description and Business Overview
6.14.3 Philips Healthcare Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Philips Healthcare Smart Medication Inhalers Product Portfolio
6.14.5 Philips Healthcare Recent Developments/Updates
6.15 Vectura
6.15.1 Vectura Corporation Information
6.15.2 Vectura Smart Medication Inhalers Description and Business Overview
6.15.3 Vectura Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Vectura Smart Medication Inhalers Product Portfolio
6.15.5 Vectura Recent Developments/Updates
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Corporation Information
6.16.2 Boehringer Ingelheim Smart Medication Inhalers Description and Business Overview
6.16.3 Boehringer Ingelheim Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Boehringer Ingelheim Smart Medication Inhalers Product Portfolio
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.17 AstraZeneca
6.17.1 AstraZeneca Corporation Information
6.17.2 AstraZeneca Smart Medication Inhalers Description and Business Overview
6.17.3 AstraZeneca Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.17.4 AstraZeneca Smart Medication Inhalers Product Portfolio
6.17.5 AstraZeneca Recent Developments/Updates
6.18 Novartis
6.18.1 Novartis Corporation Information
6.18.2 Novartis Smart Medication Inhalers Description and Business Overview
6.18.3 Novartis Smart Medication Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Novartis Smart Medication Inhalers Product Portfolio
6.18.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Smart Medication Inhalers Industry Chain Analysis
7.2 Smart Medication Inhalers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Smart Medication Inhalers Production Mode & Process
7.4 Smart Medication Inhalers Sales and Marketing
7.4.1 Smart Medication Inhalers Sales Channels
7.4.2 Smart Medication Inhalers Distributors
7.5 Smart Medication Inhalers Customers
8 Smart Medication Inhalers Market Dynamics
8.1 Smart Medication Inhalers Industry Trends
8.2 Smart Medication Inhalers Market Drivers
8.3 Smart Medication Inhalers Market Challenges
8.4 Smart Medication Inhalers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
